AD patients
N (%)
Clinical Disease pattern
Early onset AD
41 (71.9)
Adult onset AD 16 (28.1)
Persistent pattern 43 (75.4)
Relapsing pattern 14 (24.6)
Phenotype Classical flexural AD 39 (68.4)
Prurigo nodularis-like AD 7 (12.3)
Head/neck AD 4 (7.0)
Nummular type AD 3 (5.3)
Erythrodermic AD 2 (3.5)
Chronic hand eczema 2 (3.5)
Current Treatment Dupilumab 28 (49.1)
Antihistamines 10 (17.5)
Topical treatment 10 (17.5)
Cyclosporine 5 (8.7)
Upadacitinib 2 (3.5)
Methotrexate 2 (3.5)
Atopic comorbidities (asthma, rhinitis, conjunctivitis) 17 (29.8)
Thyroiditis 4 (7.0)
Alopecia 3 (5.3)
Comorbidities Hypertension 2 (3.5)
Inflammatory bowel disease 2 (3.5)
Metabolic syndrome, migraine, previous stroke, previous thyroid carcinoma, and coeliac disease 1 (1.7)
Mean ± SD
Objective and Subjective severity of AD Eczema Area and Severity Index (EASI) 9.11 ± 8.10
Patient-Oriented Eczema Measure (POEM) 12.33 ± 8.68